Future Directions and Unmet Needs of the Endometriosis Treatment Landscape

Researchers from the Feinstein Institute in Manhasset, New York, found single-cell RNA sequencing to be an effective and noninvasive way to screen for and diagnose patients with endometriosis.

Myovant Sciences and Pfizer announces the US Food and Drug Administration has approved Myfembree (relugolix combination tablets) for the once-daily treatment of moderate-to-severe endometriosis-associated pain.

Women with endometriosis had a 34% greater risk of stroke than women without the chronic inflammatory gynecological condition, according to an analysis of the Nurses Health Study II.

A review of magnetic resonance imaging (MRI) for diagnosing endometriosis and related diseases in the Korean Journal of Radiology has found that the medical imaging technique can help in the early and accurate diagnosis of ovarian endometriotic cysts and deep infiltrating endometriosis (DIE), while avoiding the need for invasive procedures and radiation exposure, due to MRI’s high contrast and objectivity.

Most studies conclude that dietary interventions positively impact endometriosis, according to a systematic review in the journal Reproductive Sciences.

A study published in Cannabis and Cannabinoid Research found that women often used cannabis to manage endometriosis symptoms during the COVID-19 pandemic.